Dengue: a clinical & hematological study
Abstract
Introduction: Dengue has positioned itself as the most important mosquito borne viral disease in the world. Current estimates report that at least 112 countries are endemic for Dengue and around 40% of the world populations are at risk in tropics and subtropics.
Objective: The objective of this study is to analyze the hematological findings in dengue illness and to correlate the same with the clinical course.
Materials and Methods: The present study was conducted in the Department of Pathology, Sree Mookambika Institute of Medical Sciences, Kulasekharam, Kanyakumari District, Tamilnadu during a period of three years from 2013 to 2015, where fifty dengue positive cases were analyzed from the Department of General Medicine.
Results: A history of fever with retroorbital pain, myalgia and headache was noted in 7(14%), 43(86%) and 50 (100%) of the cases respectively. Of the cases studied, only one (2%) of the patients had a major bleeding manifestation, whereas minor bleeding manifestations were noted in 8 (16%) of the cases. Thrombocytopenia was noted 48 patients. Leukopenia was observed in 22 (73%), while leukopenia with reversal of neutrophil lymphocyte ratio was observed in 6(20%) of the patients. A rising haematocrit was noted in (16%) of the cases.
Conclusion: It was concluded in this study that fever in the presence of thrombocytopenia, leukopenia, reversal of neutrophil lymphocyte ratio and a rising haematocrit should raise a strong suspicion of Dengue fever for which confirmation must be done. Thrombocytopenia was found to be an important prognostic indicator during hospital stay and/or follow up.
Downloads
References
2. Bäck AT, Lundkvist A. "Dengue Viruses – an overview". Infection Ecology and Epidemiology 2013;3: 19839-http://dx.doi.org/10.3402/iee.v3i0.19839.
3. Prashanth GD, Mugali SB. Persistant Thrombocytopenia in Dengue Haemorrhagic Fever. Indian Pediatrics. September 17,2011; (48): 737.
4. Funahara Y, Ogawa K, Fujita N, Okuno Y. Three possible triggers to induce thrombocytopenia in dengue virus infection. Southeast Asian J Trop Med Public Health. 1987 Sep;18(3):351-5. [PubMed]
5. Schexneider KI, Reedy EA. Thrombocytopenia in dengue fever. Curr Hematol Rep. 2005 Mar;4(2):145-8. [PubMed]
6. Lei HY, Yeh TM, Liu HS, Lin YS, Chen SH, Liu CC. Immunopathogenesis of dengue virus infection. J Biomed Sci. 2001 Sep;8(5):377-88. [PubMed]
7. Sharma SK, Aluwalia G. Dengue fever in India: An overview. Medicine Update 2010; 20: 657-59.
8. Bandyopadhyay B, Bhattacharya I,Adhikary S,Konar J,Dawar N et.al. A comprehensive study on the 2012 dengue fever outbreak in Kolkatta,India.ISRN Virology 2013;15:45-49.
9. Kassim FM, Izati MN, TgRogayah TA, Apandi YM, Saat Z. Use of dengue NS1 antigen for early diagnosis of dengue virus infection. Southeast Asian J Trop Med Public Health. 2011 May;42(3):562-9. [PubMed]
10. Arya SC, Agarwa N, Parikh SC. Detection of Dengue NS1 Antigen, Alongside IgM plus IgG and concurrent platelet enumeration during an outbreak. Asian Pacific Journal of Tropical Medicine (2011); 672-72.
11. Jalily QA et al. Screening for Dengue infection in clinically suspected cases in a Rural Teaching Hospital. J Microbiol Biotech Res 2013; 3(2):26-9.
12. Anuradha M et al. Laboratory Diagnosis and Incidence of Dengue Virus Infection: A Hospital based study, Perambalur. Int J Biomed Res 2014; 05 (03): 207-10.doi:10.7439/ijbr.
13. Saqib MA, Rafique I, Bashir S, Salam AA. A retrospective analysis of dengue fever case management and frequency of co-morbidities associated with deaths. BMC Res Notes. 2014 Apr 1;7:205. doi: 10.1186/1756-0500-7-205. [PubMed]
14. Tewari KN, Tuli NR, Devgun SC. Clinical profile of Dengue fever and use of platelets in four Tertiary Fever hospitals of Delhi in the year 2009. JIACM. 2013; 14(1):8-12.
15. Raju BJ, Rajaram G. Prevalance of Dengue fever and Dengue Haemorrhagic fever in Government General Hospital Tirupati. Int J Res Health Sci 2013; 7-9(1):23-7. [PubMed]
16. Turbadkar D, Ramachandran A, Mathur M, Gaikwad S. Laboratory and Clinical Profile of Dengue : A Study from Mumbai. Ann Trop Med Public Health 2012;5(1):20-3.
17. Mandal SK, Ganguly J, Sil K, Chatterjee S, Chatterjee K, Sarkar P et al. Clinical Profile of Dengue fever in a Teaching Hospital of Eastern India. National J Med Res; 2013; 3 (2): 173-76.
18. Kariyawasam S, Senanayake H. Dengue infections during pregnancy: case series from a tertiary care hospital in Sri Lanka. J Infect Dev Ctries. 2010 Nov 24;4(11):767-75. [PubMed]
19. Lt.Col..Banerjee M, Lt.Col Chatterjee J, Lt Col Choudhary GS, Col Srinivas V, Brig.Katari V.K . Dengue : A Clinicohaematological Profile. MJAF1 2008; 64: 333 -36. [PubMed]
20. Khan AK, Sitwat A, Masood N, Solangi NM, Shaikh TZ. Frequency and clinical Presentation of Dengue fever at Tertiary care Hospital of Hyderabad / Jamshoro; JLUMHS 2010; 9 (02) : 88-94.
21. Lin SF, Liu HW, Chung CS, Yen JH, Chen TP. Hematological Aspects of Dengue fever. Gaoxiong Yi Xue Ke Xue Za Zhi 1989; 5 (1): 12 – 16. [PubMed]
22. Fatima S, Abeddin MA, Firdous F. To Assess the severity of Dengue Fever in Patients attending a Tertiary Care teaching Hospital Using WHO Grading System. Der pharmacia letter 2013; 5 (3) : 76-80.
23. Khan MU, Rehman R, Gulfraz M , Latif W. Incidence of Thrombocytopenia in Seropositive Dengue patients. Int J Med Med Sci 2014; 6 (4) : 113 16.
24. Khan M, Kuppusamy K, Sumathi S, Mrinalini V.R. Evaluation of thrombocytopenia in Dengue Infection along with seasonal variation in rural Melmaruvathur. J Clin Diag Res 2014; 8 (1): 39-42. [PubMed]
OAI - Open Archives Initiative
